'alloxane'
(id=1827134 ; fe=alloxane ; type=1 ; niveau=200 ;
luminosité=25 ;
somme entrante=1720 creation date=2015-07-30 touchdate=2025-07-28 08:34:26.000) ≈ 512 relations sortantes
- alloxane --
r_associated #0: 86 / 1 ->
alloxanes
n1=alloxane | n2=alloxanes | rel=r_associated | relid=0 | w=86
- alloxane --
r_associated #0: 85 / 0.988 ->
en:antimitotic agent
n1=alloxane | n2=en:antimitotic agent | rel=r_associated | relid=0 | w=85
- alloxane --
r_associated #0: 85 / 0.988 ->
en:hepatotoxin
n1=alloxane | n2=en:hepatotoxin | rel=r_associated | relid=0 | w=85
- alloxane --
r_associated #0: 84 / 0.977 ->
en:antineoplastic antibiotic
n1=alloxane | n2=en:antineoplastic antibiotic | rel=r_associated | relid=0 | w=84
- alloxane --
r_associated #0: 84 / 0.977 ->
en:methotrexate
n1=alloxane | n2=en:methotrexate | rel=r_associated | relid=0 | w=84
- alloxane --
r_associated #0: 83 / 0.965 ->
en:floxuridine
n1=alloxane | n2=en:floxuridine | rel=r_associated | relid=0 | w=83
- alloxane --
r_associated #0: 82 / 0.953 ->
chimie
n1=alloxane | n2=chimie | rel=r_associated | relid=0 | w=82
- alloxane --
r_associated #0: 82 / 0.953 ->
en:eflornithine
n1=alloxane | n2=en:eflornithine | rel=r_associated | relid=0 | w=82
- alloxane --
r_associated #0: 82 / 0.953 ->
en:harringtonines
n1=alloxane | n2=en:harringtonines | rel=r_associated | relid=0 | w=82
- alloxane --
r_associated #0: 82 / 0.953 ->
en:vinblastine
n1=alloxane | n2=en:vinblastine | rel=r_associated | relid=0 | w=82
- alloxane --
r_associated #0: 81 / 0.942 ->
en:alvocidib hydrochloride
n1=alloxane | n2=en:alvocidib hydrochloride | rel=r_associated | relid=0 | w=81
- alloxane --
r_associated #0: 81 / 0.942 ->
en:animal poison
n1=alloxane | n2=en:animal poison | rel=r_associated | relid=0 | w=81
- alloxane --
r_associated #0: 81 / 0.942 ->
en:antineoplastic agents, phytogenic
n1=alloxane | n2=en:antineoplastic agents, phytogenic | rel=r_associated | relid=0 | w=81
- alloxane --
r_associated #0: 81 / 0.942 ->
en:cardiotoxins
n1=alloxane | n2=en:cardiotoxins | rel=r_associated | relid=0 | w=81
- alloxane --
r_associated #0: 81 / 0.942 ->
en:cytolysins
n1=alloxane | n2=en:cytolysins | rel=r_associated | relid=0 | w=81
- alloxane --
r_associated #0: 81 / 0.942 ->
en:pyrimidine
n1=alloxane | n2=en:pyrimidine | rel=r_associated | relid=0 | w=81
- alloxane --
r_associated #0: 80 / 0.93 ->
en:fluorouracil
n1=alloxane | n2=en:fluorouracil | rel=r_associated | relid=0 | w=80
- alloxane --
r_associated #0: 80 / 0.93 ->
en:pyrimethamine
n1=alloxane | n2=en:pyrimethamine | rel=r_associated | relid=0 | w=80
- alloxane --
r_associated #0: 80 / 0.93 ->
en:thiotepa
n1=alloxane | n2=en:thiotepa | rel=r_associated | relid=0 | w=80
- alloxane --
r_associated #0: 79 / 0.919 ->
en:cladribine
n1=alloxane | n2=en:cladribine | rel=r_associated | relid=0 | w=79
- alloxane --
r_associated #0: 79 / 0.919 ->
en:ifosfamide
n1=alloxane | n2=en:ifosfamide | rel=r_associated | relid=0 | w=79
- alloxane --
r_associated #0: 79 / 0.919 ->
en:risperidone
n1=alloxane | n2=en:risperidone | rel=r_associated | relid=0 | w=79
- alloxane --
r_associated #0: 78 / 0.907 ->
en:cytosine
n1=alloxane | n2=en:cytosine | rel=r_associated | relid=0 | w=78
- alloxane --
r_associated #0: 78 / 0.907 ->
en:enterotoxin
n1=alloxane | n2=en:enterotoxin | rel=r_associated | relid=0 | w=78
- alloxane --
r_associated #0: 78 / 0.907 ->
en:mycotoxin
n1=alloxane | n2=en:mycotoxin | rel=r_associated | relid=0 | w=78
- alloxane --
r_associated #0: 78 / 0.907 ->
en:tirapazamine
n1=alloxane | n2=en:tirapazamine | rel=r_associated | relid=0 | w=78
- alloxane --
r_associated #0: 77 / 0.895 ->
en:barbiturate
n1=alloxane | n2=en:barbiturate | rel=r_associated | relid=0 | w=77
- alloxane --
r_associated #0: 77 / 0.895 ->
en:lomustine
n1=alloxane | n2=en:lomustine | rel=r_associated | relid=0 | w=77
- alloxane --
r_associated #0: 77 / 0.895 ->
en:uracil
n1=alloxane | n2=en:uracil | rel=r_associated | relid=0 | w=77
- alloxane --
r_associated #0: 76 / 0.884 ->
en:anticarcinogenic agents
n1=alloxane | n2=en:anticarcinogenic agents | rel=r_associated | relid=0 | w=76
- alloxane --
r_associated #0: 76 / 0.884 ->
en:cytotoxin
n1=alloxane | n2=en:cytotoxin | rel=r_associated | relid=0 | w=76
- alloxane --
r_associated #0: 76 / 0.884 ->
en:dipyridamole
n1=alloxane | n2=en:dipyridamole | rel=r_associated | relid=0 | w=76
- alloxane --
r_associated #0: 76 / 0.884 ->
en:fenretinide
n1=alloxane | n2=en:fenretinide | rel=r_associated | relid=0 | w=76
- alloxane --
r_associated #0: 76 / 0.884 ->
en:phytotoxin
n1=alloxane | n2=en:phytotoxin | rel=r_associated | relid=0 | w=76
- alloxane --
r_associated #0: 76 / 0.884 ->
en:procarbazine
n1=alloxane | n2=en:procarbazine | rel=r_associated | relid=0 | w=76
- alloxane --
r_associated #0: 58 / 0.674 ->
en:aminopterin
n1=alloxane | n2=en:aminopterin | rel=r_associated | relid=0 | w=58
- alloxane --
r_associated #0: 35 / 0.407 ->
en:respiratory toxin
n1=alloxane | n2=en:respiratory toxin | rel=r_associated | relid=0 | w=35
- alloxane --
r_associated #0: 35 / 0.407 ->
en:temozolomide
n1=alloxane | n2=en:temozolomide | rel=r_associated | relid=0 | w=35
- alloxane --
r_associated #0: 34 / 0.395 ->
en:mitoxantrone
n1=alloxane | n2=en:mitoxantrone | rel=r_associated | relid=0 | w=34
- alloxane --
r_associated #0: 31 / 0.36 ->
en:etoposide
n1=alloxane | n2=en:etoposide | rel=r_associated | relid=0 | w=31
- alloxane --
r_associated #0: 31 / 0.36 ->
en:mechlorethamine
n1=alloxane | n2=en:mechlorethamine | rel=r_associated | relid=0 | w=31
- alloxane --
r_associated #0: 31 / 0.36 ->
en:orotate
n1=alloxane | n2=en:orotate | rel=r_associated | relid=0 | w=31
- alloxane --
r_associated #0: 29 / 0.337 ->
en:busulfan
n1=alloxane | n2=en:busulfan | rel=r_associated | relid=0 | w=29
- alloxane --
r_associated #0: 28 / 0.326 ->
en:irinotecan
n1=alloxane | n2=en:irinotecan | rel=r_associated | relid=0 | w=28
- alloxane --
r_associated #0: 27 / 0.314 ->
en:chlorambucil
n1=alloxane | n2=en:chlorambucil | rel=r_associated | relid=0 | w=27
- alloxane --
r_associated #0: 26 / 0.302 ->
en:alloxan
n1=alloxane | n2=en:alloxan | rel=r_associated | relid=0 | w=26
- alloxane --
r_associated #0: 5 / 0.058 ->
5 FU
n1=alloxane | n2=5 FU | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
acide adipique
n1=alloxane | n2=acide adipique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Acide formique
n1=alloxane | n2=Acide formique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
acide formique
n1=alloxane | n2=acide formique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
acide lactique
n1=alloxane | n2=acide lactique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Acide lactique
n1=alloxane | n2=Acide lactique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
acide méthanoïque
n1=alloxane | n2=acide méthanoïque | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Acide méthanoïque
n1=alloxane | n2=Acide méthanoïque | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
acide oxalique
n1=alloxane | n2=acide oxalique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Acide oxalique
n1=alloxane | n2=Acide oxalique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
acide pyrogallique
n1=alloxane | n2=acide pyrogallique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
agent antinéoplasique
n1=alloxane | n2=agent antinéoplasique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
agent tensioactif
n1=alloxane | n2=agent tensioactif | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
agents cardiotoxiques
n1=alloxane | n2=agents cardiotoxiques | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
agoniste myelo ablatif
n1=alloxane | n2=agoniste myelo ablatif | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
agonistes myelo ablatifs
n1=alloxane | n2=agonistes myelo ablatifs | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
agonistes myelo-ablatifs
n1=alloxane | n2=agonistes myelo-ablatifs | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
agonistes myélo-ablatifs
n1=alloxane | n2=agonistes myélo-ablatifs | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
agonistes myéloablatifs
n1=alloxane | n2=agonistes myéloablatifs | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
anti-androgène
n1=alloxane | n2=anti-androgène | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
antiandrogène
n1=alloxane | n2=antiandrogène | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
antibiotique antineoplasique
n1=alloxane | n2=antibiotique antineoplasique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
antibiotique antinéoplasique
n1=alloxane | n2=antibiotique antinéoplasique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
antienzyme
n1=alloxane | n2=antienzyme | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
antimétabolite
n1=alloxane | n2=antimétabolite | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
antioestrogène synthétique
n1=alloxane | n2=antioestrogène synthétique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
ASF (anglais)
n1=alloxane | n2=ASF (anglais) | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
asparaginase
n1=alloxane | n2=asparaginase | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
bevacizumab
n1=alloxane | n2=bevacizumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
bromoforme
n1=alloxane | n2=bromoforme | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
busulfan
n1=alloxane | n2=busulfan | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
butane
n1=alloxane | n2=butane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
butané
n1=alloxane | n2=butané | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
cannabidiol
n1=alloxane | n2=cannabidiol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
carmustine
n1=alloxane | n2=carmustine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
ceritinib
n1=alloxane | n2=ceritinib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
chlorure d'aluminium
n1=alloxane | n2=chlorure d'aluminium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Chlorure d'aluminium
n1=alloxane | n2=Chlorure d'aluminium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
cis-diaminedichloroplatine
n1=alloxane | n2=cis-diaminedichloroplatine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
cisplatine
n1=alloxane | n2=cisplatine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
cyclophosphamide
n1=alloxane | n2=cyclophosphamide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
cyprotérone
n1=alloxane | n2=cyprotérone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
daratumumab
n1=alloxane | n2=daratumumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
dasatinib
n1=alloxane | n2=dasatinib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
désincrustant
n1=alloxane | n2=désincrustant | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
dichlorodifluorométhane
n1=alloxane | n2=dichlorodifluorométhane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
diéthylstilbestrol
n1=alloxane | n2=diéthylstilbestrol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
diéthylstilboestrol
n1=alloxane | n2=diéthylstilboestrol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
E236
n1=alloxane | n2=E236 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
E270
n1=alloxane | n2=E270 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
E355
n1=alloxane | n2=E355 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
E553(iii)
n1=alloxane | n2=E553(iii) | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
E621
n1=alloxane | n2=E621 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
E940
n1=alloxane | n2=E940 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:2-fluorofucose-containing sgn-2ff
n1=alloxane | n2=en:2-fluorofucose-containing sgn-2ff | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:2-hydroxyoleic acid
n1=alloxane | n2=en:2-hydroxyoleic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:abarelix
n1=alloxane | n2=en:abarelix | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:acetophenone
n1=alloxane | n2=en:acetophenone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:acid of milk
n1=alloxane | n2=en:acid of milk | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:acivicin
n1=alloxane | n2=en:acivicin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:adipic acid
n1=alloxane | n2=en:adipic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:agonists
n1=alloxane | n2=en:agonists | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:alectinib
n1=alloxane | n2=en:alectinib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:alginic acid
n1=alloxane | n2=en:alginic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:alkylating agent
n1=alloxane | n2=en:alkylating agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:alloxan 6 [hp_x] oral pellet
n1=alloxane | n2=en:alloxan 6 [hp_x] oral pellet | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:alpha-gal glycosphingolipids
n1=alloxane | n2=en:alpha-gal glycosphingolipids | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:alpha-tocopheryloxyacetic acid
n1=alloxane | n2=en:alpha-tocopheryloxyacetic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:aluminium chloride
n1=alloxane | n2=en:aluminium chloride | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:aluminum chloride
n1=alloxane | n2=en:aluminum chloride | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:aluminum silicate
n1=alloxane | n2=en:aluminum silicate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ambazone
n1=alloxane | n2=en:ambazone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:amidino tic
n1=alloxane | n2=en:amidino tic | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:aminopyrimidine
n1=alloxane | n2=en:aminopyrimidine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ammonium glycyrrhizate
n1=alloxane | n2=en:ammonium glycyrrhizate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:anti-androgen
n1=alloxane | n2=en:anti-androgen | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:anti-nucleolin aptamer as1411
n1=alloxane | n2=en:anti-nucleolin aptamer as1411 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:anti-pkn3 sirna atu027
n1=alloxane | n2=en:anti-pkn3 sirna atu027 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:anti-vegf anticalin prs-050-peg40
n1=alloxane | n2=en:anti-vegf anticalin prs-050-peg40 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antienzyme.
n1=alloxane | n2=en:antienzyme. | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antileukemic agent
n1=alloxane | n2=en:antileukemic agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antimetabolite
n1=alloxane | n2=en:antimetabolite | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antimetastatic agent
n1=alloxane | n2=en:antimetastatic agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic adjuvants
n1=alloxane | n2=en:antineoplastic adjuvants | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic agent
n1=alloxane | n2=en:antineoplastic agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic agent combination sm-88
n1=alloxane | n2=en:antineoplastic agent combination sm-88 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic agent trx-818
n1=alloxane | n2=en:antineoplastic agent trx-818 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic agents, hormonal
n1=alloxane | n2=en:antineoplastic agents, hormonal | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic anthraquinone
n1=alloxane | n2=en:antineoplastic anthraquinone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic metal complex agent
n1=alloxane | n2=en:antineoplastic metal complex agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic metal complex preparation
n1=alloxane | n2=en:antineoplastic metal complex preparation | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic protein inhibitor
n1=alloxane | n2=en:antineoplastic protein inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic radiopharmaceutical agent
n1=alloxane | n2=en:antineoplastic radiopharmaceutical agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:antineoplastic vinca alkaloid
n1=alloxane | n2=en:antineoplastic vinca alkaloid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:apoptosis inducer bzl101
n1=alloxane | n2=en:apoptosis inducer bzl101 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:apoptosis inducer mpc-2130
n1=alloxane | n2=en:apoptosis inducer mpc-2130 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:apoptotic pathway-targeting antineoplastic agent
n1=alloxane | n2=en:apoptotic pathway-targeting antineoplastic agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:aromatase inhibitor
n1=alloxane | n2=en:aromatase inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:artemether sublingual spray
n1=alloxane | n2=en:artemether sublingual spray | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ascorbic acid 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / acetaldehyde 6 [hp_x] in 1 ml / prasterone 6 [hp_x] in 1 ml / insuli
n1=alloxane | n2=en:ascorbic acid 6 [hp_x] in 1 ml / pyridoxine hydrochloride 6 [hp_x] in 1 ml / riboflavin 6 [hp_x] in 1 ml / lactic acid, l- 6 [hp_x] in 1 ml / thiamine hydrochloride 6 [hp_x] in 1 ml / acetaldehyde 6 [hp_x] in 1 ml / prasterone 6 [hp_x] in 1 ml / insuli | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:asp4132
n1=alloxane | n2=en:asp4132 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:asp9853
n1=alloxane | n2=en:asp9853 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:asparaginase
n1=alloxane | n2=en:asparaginase | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:atr-101
n1=alloxane | n2=en:atr-101 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:azapicyl
n1=alloxane | n2=en:azapicyl | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:azurin:50-77 cell penetrating peptide p28
n1=alloxane | n2=en:azurin:50-77 cell penetrating peptide p28 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bc-819 plasmid/polyethylenimine complex
n1=alloxane | n2=en:bc-819 plasmid/polyethylenimine complex | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bcl-2 inhibitor bcl201
n1=alloxane | n2=en:bcl-2 inhibitor bcl201 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:belinostat
n1=alloxane | n2=en:belinostat | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:benaxibine
n1=alloxane | n2=en:benaxibine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bet inhibitor
n1=alloxane | n2=en:bet inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:beta-elemene
n1=alloxane | n2=en:beta-elemene | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:beta-lapachone prodrug arq 761
n1=alloxane | n2=en:beta-lapachone prodrug arq 761 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bevacizumab
n1=alloxane | n2=en:bevacizumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bexarotene
n1=alloxane | n2=en:bexarotene | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bh3 mimetic abt-737
n1=alloxane | n2=en:bh3 mimetic abt-737 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bicalutamide
n1=alloxane | n2=en:bicalutamide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex
n1=alloxane | n2=en:bifunctional expression vector plasmid dna-bi-shrna ews/fli1 type 1 lipoplex | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:binimetinib-containing product
n1=alloxane | n2=en:binimetinib-containing product | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:birinapant
n1=alloxane | n2=en:birinapant | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:braf inhibitor
n1=alloxane | n2=en:braf inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:breflate
n1=alloxane | n2=en:breflate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bromacrylide
n1=alloxane | n2=en:bromacrylide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bromoform
n1=alloxane | n2=en:bromoform | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:bryostatin 1
n1=alloxane | n2=en:bryostatin 1 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:budotitane
n1=alloxane | n2=en:budotitane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:butane
n1=alloxane | n2=en:butane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:calcium sulfate anhydrous
n1=alloxane | n2=en:calcium sulfate anhydrous | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:calcium sulfate hemihydrate
n1=alloxane | n2=en:calcium sulfate hemihydrate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:calculus bovis/moschus/olibanum/myrrha capsule
n1=alloxane | n2=en:calculus bovis/moschus/olibanum/myrrha capsule | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cancell
n1=alloxane | n2=en:cancell | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cannabidiol
n1=alloxane | n2=en:cannabidiol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:caramel
n1=alloxane | n2=en:caramel | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:carbohydrate processing inhibitor
n1=alloxane | n2=en:carbohydrate processing inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:carboxyamidotriazole orotate
n1=alloxane | n2=en:carboxyamidotriazole orotate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:caricotamide/tretazicar
n1=alloxane | n2=en:caricotamide/tretazicar | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:carmustine
n1=alloxane | n2=en:carmustine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:catumaxomab
n1=alloxane | n2=en:catumaxomab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cd47 antagonist alx148
n1=alloxane | n2=en:cd47 antagonist alx148 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cd5789 cream
n1=alloxane | n2=en:cd5789 cream | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cebpa-targeting sarna mtl-cebpa liposome
n1=alloxane | n2=en:cebpa-targeting sarna mtl-cebpa liposome | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cedefingol
n1=alloxane | n2=en:cedefingol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cell differentiating agent
n1=alloxane | n2=en:cell differentiating agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cephalostatin
n1=alloxane | n2=en:cephalostatin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ceramide nanoliposome
n1=alloxane | n2=en:ceramide nanoliposome | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ceritinib
n1=alloxane | n2=en:ceritinib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:chemotherapeutic topical agent
n1=alloxane | n2=en:chemotherapeutic topical agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:chk1 inhibitor gdc-0425
n1=alloxane | n2=en:chk1 inhibitor gdc-0425 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:chlorotoxin [131i]
n1=alloxane | n2=en:chlorotoxin [131i] | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cinnamaldehyde
n1=alloxane | n2=en:cinnamaldehyde | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cinobufagin
n1=alloxane | n2=en:cinobufagin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cisplatin
n1=alloxane | n2=en:cisplatin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cisplatin/vinblastine/cell penetration enhancer formulation int230-6
n1=alloxane | n2=en:cisplatin/vinblastine/cell penetration enhancer formulation int230-6 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cisplatinum
n1=alloxane | n2=en:cisplatinum | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ck2-targeting synthetic peptide cigb-300
n1=alloxane | n2=en:ck2-targeting synthetic peptide cigb-300 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:clanfenur
n1=alloxane | n2=en:clanfenur | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cleanser
n1=alloxane | n2=en:cleanser | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:compound kushen injection
n1=alloxane | n2=en:compound kushen injection | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:contrast agent
n1=alloxane | n2=en:contrast agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:contrast media
n1=alloxane | n2=en:contrast media | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:crotonaldehyde
n1=alloxane | n2=en:crotonaldehyde | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cxcr4 peptide antagonist ly2510924
n1=alloxane | n2=en:cxcr4 peptide antagonist ly2510924 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cycle-phase nonspecific agent
n1=alloxane | n2=en:cycle-phase nonspecific agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cyclophosphamide
n1=alloxane | n2=en:cyclophosphamide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cyproterone
n1=alloxane | n2=en:cyproterone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cytokine agent
n1=alloxane | n2=en:cytokine agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cytoprotective agent
n1=alloxane | n2=en:cytoprotective agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:cytostatic agents
n1=alloxane | n2=en:cytostatic agents | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:daratumumab
n1=alloxane | n2=en:daratumumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:darinaparsin
n1=alloxane | n2=en:darinaparsin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dasatinib
n1=alloxane | n2=en:dasatinib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:demethylating agent
n1=alloxane | n2=en:demethylating agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:detergent
n1=alloxane | n2=en:detergent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:diarylsulfonylurea compound
n1=alloxane | n2=en:diarylsulfonylurea compound | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dichlorodifluoromethane
n1=alloxane | n2=en:dichlorodifluoromethane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dichlorofluoromethane
n1=alloxane | n2=en:dichlorofluoromethane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dichlorotetrafluoroethane
n1=alloxane | n2=en:dichlorotetrafluoroethane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:diethylstilbestrol
n1=alloxane | n2=en:diethylstilbestrol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dimethyl sulfoxide
n1=alloxane | n2=en:dimethyl sulfoxide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dl-lactic acid
n1=alloxane | n2=en:dl-lactic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dna binding agent
n1=alloxane | n2=en:dna binding agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dna-rna transcription regulator
n1=alloxane | n2=en:dna-rna transcription regulator | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dopamine-somatostatin chimeric molecule bim-23a760
n1=alloxane | n2=en:dopamine-somatostatin chimeric molecule bim-23a760 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dta-h19 plasmid
n1=alloxane | n2=en:dta-h19 plasmid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:dye
n1=alloxane | n2=en:dye | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:e-selectin antagonist gmi-1271
n1=alloxane | n2=en:e-selectin antagonist gmi-1271 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:e2f1 pathway activator arq 171
n1=alloxane | n2=en:e2f1 pathway activator arq 171 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:elesclomol
n1=alloxane | n2=en:elesclomol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:elesclomol sodium
n1=alloxane | n2=en:elesclomol sodium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:elotuzumab
n1=alloxane | n2=en:elotuzumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:endotoxin
n1=alloxane | n2=en:endotoxin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:enteric-coated trpm8 agonist d-3263 hydrochloride
n1=alloxane | n2=en:enteric-coated trpm8 agonist d-3263 hydrochloride | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:enzalutamide
n1=alloxane | n2=en:enzalutamide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:enzyme inhibitor
n1=alloxane | n2=en:enzyme inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ep4 receptor antagonist aat-007
n1=alloxane | n2=en:ep4 receptor antagonist aat-007 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:epha2-targeting dopc-encapsulated sirna
n1=alloxane | n2=en:epha2-targeting dopc-encapsulated sirna | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:epidermal growth factor receptor antagonist [epc]
n1=alloxane | n2=en:epidermal growth factor receptor antagonist [epc] | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:epidermal growth factor receptor tyrosine kinase inhibitor
n1=alloxane | n2=en:epidermal growth factor receptor tyrosine kinase inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:epipropidine
n1=alloxane | n2=en:epipropidine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:epothilone compound
n1=alloxane | n2=en:epothilone compound | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:Epsom salt
n1=alloxane | n2=en:Epsom salt | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:epsom salt
n1=alloxane | n2=en:epsom salt | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:erastin analogue prlx 93936
n1=alloxane | n2=en:erastin analogue prlx 93936 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ethan-1,2-diol
n1=alloxane | n2=en:ethan-1,2-diol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ethanediol
n1=alloxane | n2=en:ethanediol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ethylene chlorohydrin
n1=alloxane | n2=en:ethylene chlorohydrin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ethylene glycol
n1=alloxane | n2=en:ethylene glycol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:everolimus
n1=alloxane | n2=en:everolimus | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:exposure as collected domain
n1=alloxane | n2=en:exposure as collected domain | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:factor viia inhibitor pci-27483
n1=alloxane | n2=en:factor viia inhibitor pci-27483 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:fda established names and unique ingredient identifier codes terminology
n1=alloxane | n2=en:fda established names and unique ingredient identifier codes terminology | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:finasteride
n1=alloxane | n2=en:finasteride | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:fludarabine
n1=alloxane | n2=en:fludarabine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225
n1=alloxane | n2=en:folate receptor-targeted vinca alkaloid/mitomycin c ec0225 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:formic acid
n1=alloxane | n2=en:formic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:forodesine
n1=alloxane | n2=en:forodesine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:fusion toxin
n1=alloxane | n2=en:fusion toxin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:galectin inhibitor gr-md-02
n1=alloxane | n2=en:galectin inhibitor gr-md-02 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:galectin-1 inhibitor otx008
n1=alloxane | n2=en:galectin-1 inhibitor otx008 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:gallium maltolate
n1=alloxane | n2=en:gallium maltolate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:gemcitabine
n1=alloxane | n2=en:gemcitabine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:giracodazole
n1=alloxane | n2=en:giracodazole | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:glutaral
n1=alloxane | n2=en:glutaral | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:haemato fu
n1=alloxane | n2=en:haemato fu | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hafnium oxide-containing nanoparticles nbtxr3
n1=alloxane | n2=en:hafnium oxide-containing nanoparticles nbtxr3 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:heat shock protein inhibitor
n1=alloxane | n2=en:heat shock protein inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hemotoxin
n1=alloxane | n2=en:hemotoxin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hexetidine
n1=alloxane | n2=en:hexetidine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hif-2alpha inhibitor pt2385
n1=alloxane | n2=en:hif-2alpha inhibitor pt2385 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hif-2alpha inhibitor pt2977
n1=alloxane | n2=en:hif-2alpha inhibitor pt2977 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:huachansu
n1=alloxane | n2=en:huachansu | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hydroxy(oxo)methane
n1=alloxane | n2=en:hydroxy(oxo)methane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hydroxymethanone
n1=alloxane | n2=en:hydroxymethanone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hypoglycins
n1=alloxane | n2=en:hypoglycins | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:hypoxia-activated prodrug th-302
n1=alloxane | n2=en:hypoxia-activated prodrug th-302 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:iap inhibitor at-406
n1=alloxane | n2=en:iap inhibitor at-406 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:iap inhibitor hgs1029
n1=alloxane | n2=en:iap inhibitor hgs1029 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ibritumomab
n1=alloxane | n2=en:ibritumomab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ibritumomab tiuxetan
n1=alloxane | n2=en:ibritumomab tiuxetan | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:imatinib mesylate
n1=alloxane | n2=en:imatinib mesylate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:immunology aspects
n1=alloxane | n2=en:immunology aspects | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:industrial aid
n1=alloxane | n2=en:industrial aid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ingenol mebutate
n1=alloxane | n2=en:ingenol mebutate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ingenol mebutate gel
n1=alloxane | n2=en:ingenol mebutate gel | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:inproquone
n1=alloxane | n2=en:inproquone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:intiquinatine
n1=alloxane | n2=en:intiquinatine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:intravesical bcg
n1=alloxane | n2=en:intravesical bcg | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ipilimumab
n1=alloxane | n2=en:ipilimumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:jin fu kang
n1=alloxane | n2=en:jin fu kang | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:kanglaite
n1=alloxane | n2=en:kanglaite | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:lactic acid
n1=alloxane | n2=en:lactic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:lactic acid, l-
n1=alloxane | n2=en:lactic acid, l- | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:lactoferrin-derived lytic peptide ltx-315
n1=alloxane | n2=en:lactoferrin-derived lytic peptide ltx-315 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:lapachone
n1=alloxane | n2=en:lapachone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:leuprolide
n1=alloxane | n2=en:leuprolide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:lipid encapsulated anti-plk1 sirna tkm-plk1
n1=alloxane | n2=en:lipid encapsulated anti-plk1 sirna tkm-plk1 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:liposome-encapsulated mir-34 mimic mrx34
n1=alloxane | n2=en:liposome-encapsulated mir-34 mimic mrx34 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:lubricant
n1=alloxane | n2=en:lubricant | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:magnesium aluminum silicate
n1=alloxane | n2=en:magnesium aluminum silicate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:magnesium sulfate
n1=alloxane | n2=en:magnesium sulfate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:magnesium sulfate heptahydrate
n1=alloxane | n2=en:magnesium sulfate heptahydrate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:magnesium sulphate
n1=alloxane | n2=en:magnesium sulphate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:maltose tetrapalmitate
n1=alloxane | n2=en:maltose tetrapalmitate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:marine toxins
n1=alloxane | n2=en:marine toxins | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:mcl-1 inhibitor amg 176
n1=alloxane | n2=en:mcl-1 inhibitor amg 176 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:mdm2 antagonist ro6839921
n1=alloxane | n2=en:mdm2 antagonist ro6839921 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:mdm2/mdmx inhibitor alrn-6924
n1=alloxane | n2=en:mdm2/mdmx inhibitor alrn-6924 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:mechanism of action qualifier
n1=alloxane | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:metacarbonoic acid
n1=alloxane | n2=en:metacarbonoic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:metaiodobenzylguanidine[131i]
n1=alloxane | n2=en:metaiodobenzylguanidine[131i] | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:methanoic acid
n1=alloxane | n2=en:methanoic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:methoxyamine hydrochloride
n1=alloxane | n2=en:methoxyamine hydrochloride | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:methyl benzene
n1=alloxane | n2=en:methyl benzene | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:microorganism toxin
n1=alloxane | n2=en:microorganism toxin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:mitoquidone
n1=alloxane | n2=en:mitoquidone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:modified vitamin d binding protein macrophage activator ef-022
n1=alloxane | n2=en:modified vitamin d binding protein macrophage activator ef-022 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:monoclonal antibodies, antineoplastic
n1=alloxane | n2=en:monoclonal antibodies, antineoplastic | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:monosodium glutamate
n1=alloxane | n2=en:monosodium glutamate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:morantel
n1=alloxane | n2=en:morantel | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads
n1=alloxane | n2=en:mouse renal adenocarcinoma cell-encapsulated agarose-agarose macrobeads | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:mushroom poison
n1=alloxane | n2=en:mushroom poison | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:myeloablative agonist
n1=alloxane | n2=en:myeloablative agonist | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:n,n-dimethylformamide
n1=alloxane | n2=en:n,n-dimethylformamide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:naptumomab
n1=alloxane | n2=en:naptumomab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:nicarbazin
n1=alloxane | n2=en:nicarbazin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:nilandron
n1=alloxane | n2=en:nilandron | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:nintedanib
n1=alloxane | n2=en:nintedanib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:nucleolin antagonist ipp-204106n
n1=alloxane | n2=en:nucleolin antagonist ipp-204106n | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:nutlin-3a
n1=alloxane | n2=en:nutlin-3a | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:nutritional toxin
n1=alloxane | n2=en:nutritional toxin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:obatoclax
n1=alloxane | n2=en:obatoclax | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:olaparib
n1=alloxane | n2=en:olaparib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:oregovomab
n1=alloxane | n2=en:oregovomab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:organic impurity
n1=alloxane | n2=en:organic impurity | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:oxalic acid
n1=alloxane | n2=en:oxalic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:oxocarbinic acid
n1=alloxane | n2=en:oxocarbinic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:oxyferriscorbone
n1=alloxane | n2=en:oxyferriscorbone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:oxyphencyclimine
n1=alloxane | n2=en:oxyphencyclimine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ozone-based agent
n1=alloxane | n2=en:ozone-based agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:p-cadherin-targeting agent pf-06671008
n1=alloxane | n2=en:p-cadherin-targeting agent pf-06671008 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:p53-hdm2 protein-protein interaction inhibitor apg-115
n1=alloxane | n2=en:p53-hdm2 protein-protein interaction inhibitor apg-115 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:palbociclib
n1=alloxane | n2=en:palbociclib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:paliperidone palmitate
n1=alloxane | n2=en:paliperidone palmitate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:panobinostat lactate
n1=alloxane | n2=en:panobinostat lactate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:panthenol
n1=alloxane | n2=en:panthenol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pegylated human recombinant arginase 1 aeb1102
n1=alloxane | n2=en:pegylated human recombinant arginase 1 aeb1102 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pegylated recombinant l-asparaginase erwinia chrysanthemi
n1=alloxane | n2=en:pegylated recombinant l-asparaginase erwinia chrysanthemi | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pesticide
n1=alloxane | n2=en:pesticide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pharmacokinetic aspects
n1=alloxane | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:phosphaplatin pt-112
n1=alloxane | n2=en:phosphaplatin pt-112 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:piroxicam
n1=alloxane | n2=en:piroxicam | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:plasticizer
n1=alloxane | n2=en:plasticizer | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pleiotropic pathway modifier cc-122 hydrochloride
n1=alloxane | n2=en:pleiotropic pathway modifier cc-122 hydrochloride | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:plevitrexed
n1=alloxane | n2=en:plevitrexed | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pol i inhibitor cx5461
n1=alloxane | n2=en:pol i inhibitor cx5461 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:poly (adp-ribose) polymerase inhibitor
n1=alloxane | n2=en:poly (adp-ribose) polymerase inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:polyamine analogue
n1=alloxane | n2=en:polyamine analogue | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:polyamine synthesis inhibitor
n1=alloxane | n2=en:polyamine synthesis inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pomalidomide
n1=alloxane | n2=en:pomalidomide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:prima-1 analog apr-246
n1=alloxane | n2=en:prima-1 analog apr-246 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:prohibitin-targeting peptide 1
n1=alloxane | n2=en:prohibitin-targeting peptide 1 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:propylene glycol monostearate
n1=alloxane | n2=en:propylene glycol monostearate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:proteasome inhibitor
n1=alloxane | n2=en:proteasome inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:put powder on something
n1=alloxane | n2=en:put powder on something | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:put talc on something
n1=alloxane | n2=en:put talc on something | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pyrazolopyrimidine
n1=alloxane | n2=en:pyrazolopyrimidine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:pyrogallol
n1=alloxane | n2=en:pyrogallol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:radiosensitizing agent
n1=alloxane | n2=en:radiosensitizing agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ramucirumab
n1=alloxane | n2=en:ramucirumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:renal toxin
n1=alloxane | n2=en:renal toxin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:residual solvent
n1=alloxane | n2=en:residual solvent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:retinoic acid agent
n1=alloxane | n2=en:retinoic acid agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:risperidone formulation in rumenic acid
n1=alloxane | n2=en:risperidone formulation in rumenic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ritanserin
n1=alloxane | n2=en:ritanserin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:rituximab
n1=alloxane | n2=en:rituximab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:ruxolitinib
n1=alloxane | n2=en:ruxolitinib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:saline
n1=alloxane | n2=en:saline | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:salt solution
n1=alloxane | n2=en:salt solution | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:selective estrogen receptor modulator
n1=alloxane | n2=en:selective estrogen receptor modulator | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:selinexor
n1=alloxane | n2=en:selinexor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:signal transduction inhibitor
n1=alloxane | n2=en:signal transduction inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:simtrazene
n1=alloxane | n2=en:simtrazene | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:smac mimetic gdc-0917
n1=alloxane | n2=en:smac mimetic gdc-0917 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:soapstone
n1=alloxane | n2=en:soapstone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:sodium glutamate
n1=alloxane | n2=en:sodium glutamate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:sparsomycin
n1=alloxane | n2=en:sparsomycin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:splicing inhibitor h3b-8800
n1=alloxane | n2=en:splicing inhibitor h3b-8800 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:sr-t100 gel
n1=alloxane | n2=en:sr-t100 gel | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:standards characteristics
n1=alloxane | n2=en:standards characteristics | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:steatite
n1=alloxane | n2=en:steatite | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:surface-active agent
n1=alloxane | n2=en:surface-active agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:surfactant agent
n1=alloxane | n2=en:surfactant agent | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:synthesis inhibitors, dna
n1=alloxane | n2=en:synthesis inhibitors, dna | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:synthetic antiandrogen
n1=alloxane | n2=en:synthetic antiandrogen | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:synthetic antiestrogen
n1=alloxane | n2=en:synthetic antiestrogen | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:talc
n1=alloxane | n2=en:talc | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:talcum
n1=alloxane | n2=en:talcum | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:talcum powder
n1=alloxane | n2=en:talcum powder | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:talimogene laherparepvec
n1=alloxane | n2=en:talimogene laherparepvec | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tasisulam
n1=alloxane | n2=en:tasisulam | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tasisulam sodium
n1=alloxane | n2=en:tasisulam sodium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:taurultam
n1=alloxane | n2=en:taurultam | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:teglarinad
n1=alloxane | n2=en:teglarinad | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:temsirolimus
n1=alloxane | n2=en:temsirolimus | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:terfluranol
n1=alloxane | n2=en:terfluranol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tgfbeta inhibitor ly3200882
n1=alloxane | n2=en:tgfbeta inhibitor ly3200882 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:therapeutic use - qualifier
n1=alloxane | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:thiamine
n1=alloxane | n2=en:thiamine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:thimerfonate sodium
n1=alloxane | n2=en:thimerfonate sodium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:thioureidobutyronitrile
n1=alloxane | n2=en:thioureidobutyronitrile | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:thyrotropin alfa
n1=alloxane | n2=en:thyrotropin alfa | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tigapotide
n1=alloxane | n2=en:tigapotide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tilorone
n1=alloxane | n2=en:tilorone | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tolnidamine
n1=alloxane | n2=en:tolnidamine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:toloconium metilsulfate
n1=alloxane | n2=en:toloconium metilsulfate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:toluene
n1=alloxane | n2=en:toluene | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:topical betulinic acid
n1=alloxane | n2=en:topical betulinic acid | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:topoisomerase inhibitor
n1=alloxane | n2=en:topoisomerase inhibitor | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tositumomab
n1=alloxane | n2=en:tositumomab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:toxin
n1=alloxane | n2=en:toxin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:trapidil
n1=alloxane | n2=en:trapidil | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:trastuzumab
n1=alloxane | n2=en:trastuzumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tretazicar
n1=alloxane | n2=en:tretazicar | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tribasic potassium phosphate
n1=alloxane | n2=en:tribasic potassium phosphate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:trichloroethane
n1=alloxane | n2=en:trichloroethane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:trichloromonofluoromethane
n1=alloxane | n2=en:trichloromonofluoromethane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:trimetrexate
n1=alloxane | n2=en:trimetrexate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tripalmitin
n1=alloxane | n2=en:tripalmitin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:tyroserleutide
n1=alloxane | n2=en:tyroserleutide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:urethan
n1=alloxane | n2=en:urethan | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:urethane
n1=alloxane | n2=en:urethane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:vegf/hgf-targeting darpin mp0250
n1=alloxane | n2=en:vegf/hgf-targeting darpin mp0250 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:verteporfin
n1=alloxane | n2=en:verteporfin | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:yangzheng xiaoji extract
n1=alloxane | n2=en:yangzheng xiaoji extract | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:zanolimumab
n1=alloxane | n2=en:zanolimumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:zein
n1=alloxane | n2=en:zein | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:zinc finger nuclease zfn-603
n1=alloxane | n2=en:zinc finger nuclease zfn-603 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
en:zinc finger nuclease zfn-758
n1=alloxane | n2=en:zinc finger nuclease zfn-758 | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
endotoxine
n1=alloxane | n2=endotoxine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
enzalutamide
n1=alloxane | n2=enzalutamide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
éthylène glycol
n1=alloxane | n2=éthylène glycol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Éthylène glycol
n1=alloxane | n2=Éthylène glycol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
éthylène-glycol
n1=alloxane | n2=éthylène-glycol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
éthylèneglycol
n1=alloxane | n2=éthylèneglycol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
finastéride
n1=alloxane | n2=finastéride | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
fludarabine
n1=alloxane | n2=fludarabine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
fluoro-uracile
n1=alloxane | n2=fluoro-uracile | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
fluorouracile
n1=alloxane | n2=fluorouracile | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
gemcitabine
n1=alloxane | n2=gemcitabine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
glutamate de sodium
n1=alloxane | n2=glutamate de sodium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
glutamate monosodique
n1=alloxane | n2=glutamate monosodique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Glutamate monosodique
n1=alloxane | n2=Glutamate monosodique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
glycol éthylique
n1=alloxane | n2=glycol éthylique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
GMS
n1=alloxane | n2=GMS | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
GMS
(glutamate monosodique)
n1=alloxane | n2=GMS (glutamate monosodique) | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
graisse de machines
n1=alloxane | n2=graisse de machines | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
hexétidine
n1=alloxane | n2=hexétidine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
inhibiteur d'enzymes
n1=alloxane | n2=inhibiteur d'enzymes | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
inhibiteur de l'aromatase
n1=alloxane | n2=inhibiteur de l'aromatase | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
inhibiteur de transduction du signal
n1=alloxane | n2=inhibiteur de transduction du signal | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
inhibiteur enzymatique
n1=alloxane | n2=inhibiteur enzymatique | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
inhibiteurs de l'aromatase
n1=alloxane | n2=inhibiteurs de l'aromatase | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
ipilimumab
n1=alloxane | n2=ipilimumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
irinotecan
n1=alloxane | n2=irinotecan | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
modulateur sélectif des récepteurs ?strogéniques
n1=alloxane | n2=modulateur sélectif des récepteurs ?strogéniques | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
monosodium glutamate
n1=alloxane | n2=monosodium glutamate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
MSG
n1=alloxane | n2=MSG | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
mycotoxine
n1=alloxane | n2=mycotoxine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
mycotoxines
n1=alloxane | n2=mycotoxines | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
olaparib
n1=alloxane | n2=olaparib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
orotate
n1=alloxane | n2=orotate | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
palbociclib
n1=alloxane | n2=palbociclib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
pesticide
n1=alloxane | n2=pesticide | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
pierre à savon
n1=alloxane | n2=pierre à savon | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Pierre à savon
n1=alloxane | n2=Pierre à savon | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
piroxicam
n1=alloxane | n2=piroxicam | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
plastifiant
n1=alloxane | n2=plastifiant | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
poison provenant de champignons
n1=alloxane | n2=poison provenant de champignons | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
poudrer
n1=alloxane | n2=poudrer | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
procarbazine
n1=alloxane | n2=procarbazine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
produit de contraste
n1=alloxane | n2=produit de contraste | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
pyrogallol
n1=alloxane | n2=pyrogallol | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
pyrogallols
n1=alloxane | n2=pyrogallols | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
ramucirumab
n1=alloxane | n2=ramucirumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
rituximab
n1=alloxane | n2=rituximab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
ruxolitinib
n1=alloxane | n2=ruxolitinib | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
sel d'Epsom
n1=alloxane | n2=sel d'Epsom | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
silicate d'aluminium
n1=alloxane | n2=silicate d'aluminium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
Silicate d'aluminium
n1=alloxane | n2=Silicate d'aluminium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
solution salée
n1=alloxane | n2=solution salée | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
stéatite
n1=alloxane | n2=stéatite | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
sulfate de magnésie
n1=alloxane | n2=sulfate de magnésie | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
sulfate de magnésium
n1=alloxane | n2=sulfate de magnésium | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
talc
n1=alloxane | n2=talc | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
talquer [qch]
n1=alloxane | n2=talquer [qch] | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
temsirolimus
n1=alloxane | n2=temsirolimus | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
thiamine
n1=alloxane | n2=thiamine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
thyrotropine alfa
n1=alloxane | n2=thyrotropine alfa | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
tolène
n1=alloxane | n2=tolène | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
toluène
n1=alloxane | n2=toluène | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
trastuzumab
n1=alloxane | n2=trastuzumab | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
tripalmitine
n1=alloxane | n2=tripalmitine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
uréthane
n1=alloxane | n2=uréthane | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
vinblastine
n1=alloxane | n2=vinblastine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 5 / 0.058 ->
zéine
n1=alloxane | n2=zéine | rel=r_associated | relid=0 | w=5
- alloxane --
r_associated #0: 2 / 0.023 ->
toxine
n1=alloxane | n2=toxine | rel=r_associated | relid=0 | w=2
| ≈ 69 relations entrantes
- alloxanes ---
r_associated #0: 34 -->
alloxane
n1=alloxanes | n2=alloxane | rel=r_associated | relid=0 | w=34
- en:alloxan ---
r_associated #0: 34 -->
alloxane
n1=en:alloxan | n2=alloxane | rel=r_associated | relid=0 | w=34
- chimie ---
r_associated #0: 27 -->
alloxane
n1=chimie | n2=alloxane | rel=r_associated | relid=0 | w=27
- en:alvocidib hydrochloride ---
r_associated #0: 20 -->
alloxane
n1=en:alvocidib hydrochloride | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:aminopterin ---
r_associated #0: 20 -->
alloxane
n1=en:aminopterin | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:animal poison ---
r_associated #0: 20 -->
alloxane
n1=en:animal poison | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:anticarcinogenic agents ---
r_associated #0: 20 -->
alloxane
n1=en:anticarcinogenic agents | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:antimitotic agent ---
r_associated #0: 20 -->
alloxane
n1=en:antimitotic agent | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:antineoplastic agents, phytogenic ---
r_associated #0: 20 -->
alloxane
n1=en:antineoplastic agents, phytogenic | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:antineoplastic antibiotic ---
r_associated #0: 20 -->
alloxane
n1=en:antineoplastic antibiotic | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:barbiturate ---
r_associated #0: 20 -->
alloxane
n1=en:barbiturate | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:busulfan ---
r_associated #0: 20 -->
alloxane
n1=en:busulfan | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:cardiotoxins ---
r_associated #0: 20 -->
alloxane
n1=en:cardiotoxins | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:chlorambucil ---
r_associated #0: 20 -->
alloxane
n1=en:chlorambucil | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:cladribine ---
r_associated #0: 20 -->
alloxane
n1=en:cladribine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:cytolysins ---
r_associated #0: 20 -->
alloxane
n1=en:cytolysins | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:cytosine ---
r_associated #0: 20 -->
alloxane
n1=en:cytosine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:cytotoxin ---
r_associated #0: 20 -->
alloxane
n1=en:cytotoxin | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:dipyridamole ---
r_associated #0: 20 -->
alloxane
n1=en:dipyridamole | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:eflornithine ---
r_associated #0: 20 -->
alloxane
n1=en:eflornithine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:enterotoxin ---
r_associated #0: 20 -->
alloxane
n1=en:enterotoxin | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:etoposide ---
r_associated #0: 20 -->
alloxane
n1=en:etoposide | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:fenretinide ---
r_associated #0: 20 -->
alloxane
n1=en:fenretinide | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:floxuridine ---
r_associated #0: 20 -->
alloxane
n1=en:floxuridine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:fluorouracil ---
r_associated #0: 20 -->
alloxane
n1=en:fluorouracil | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:harringtonines ---
r_associated #0: 20 -->
alloxane
n1=en:harringtonines | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:hepatotoxin ---
r_associated #0: 20 -->
alloxane
n1=en:hepatotoxin | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:ifosfamide ---
r_associated #0: 20 -->
alloxane
n1=en:ifosfamide | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:irinotecan ---
r_associated #0: 20 -->
alloxane
n1=en:irinotecan | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:lomustine ---
r_associated #0: 20 -->
alloxane
n1=en:lomustine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:mechlorethamine ---
r_associated #0: 20 -->
alloxane
n1=en:mechlorethamine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:methotrexate ---
r_associated #0: 20 -->
alloxane
n1=en:methotrexate | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:mitoxantrone ---
r_associated #0: 20 -->
alloxane
n1=en:mitoxantrone | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:mycotoxin ---
r_associated #0: 20 -->
alloxane
n1=en:mycotoxin | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:orotate ---
r_associated #0: 20 -->
alloxane
n1=en:orotate | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:phytotoxin ---
r_associated #0: 20 -->
alloxane
n1=en:phytotoxin | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:procarbazine ---
r_associated #0: 20 -->
alloxane
n1=en:procarbazine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:pyrimethamine ---
r_associated #0: 20 -->
alloxane
n1=en:pyrimethamine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:pyrimidine ---
r_associated #0: 20 -->
alloxane
n1=en:pyrimidine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:respiratory toxin ---
r_associated #0: 20 -->
alloxane
n1=en:respiratory toxin | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:risperidone ---
r_associated #0: 20 -->
alloxane
n1=en:risperidone | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:temozolomide ---
r_associated #0: 20 -->
alloxane
n1=en:temozolomide | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:thiotepa ---
r_associated #0: 20 -->
alloxane
n1=en:thiotepa | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:tirapazamine ---
r_associated #0: 20 -->
alloxane
n1=en:tirapazamine | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:uracil ---
r_associated #0: 20 -->
alloxane
n1=en:uracil | n2=alloxane | rel=r_associated | relid=0 | w=20
- en:vinblastine ---
r_associated #0: 20 -->
alloxane
n1=en:vinblastine | n2=alloxane | rel=r_associated | relid=0 | w=20
- busulfan ---
r_associated #0: 10 -->
alloxane
n1=busulfan | n2=alloxane | rel=r_associated | relid=0 | w=10
- chlorambucil ---
r_associated #0: 10 -->
alloxane
n1=chlorambucil | n2=alloxane | rel=r_associated | relid=0 | w=10
- cytotoxine ---
r_associated #0: 10 -->
alloxane
n1=cytotoxine | n2=alloxane | rel=r_associated | relid=0 | w=10
- entérotoxine ---
r_associated #0: 10 -->
alloxane
n1=entérotoxine | n2=alloxane | rel=r_associated | relid=0 | w=10
- floxuridine ---
r_associated #0: 10 -->
alloxane
n1=floxuridine | n2=alloxane | rel=r_associated | relid=0 | w=10
- fluorouracile ---
r_associated #0: 10 -->
alloxane
n1=fluorouracile | n2=alloxane | rel=r_associated | relid=0 | w=10
- ifosfamide ---
r_associated #0: 10 -->
alloxane
n1=ifosfamide | n2=alloxane | rel=r_associated | relid=0 | w=10
- irinotecan ---
r_associated #0: 10 -->
alloxane
n1=irinotecan | n2=alloxane | rel=r_associated | relid=0 | w=10
- lomustine ---
r_associated #0: 10 -->
alloxane
n1=lomustine | n2=alloxane | rel=r_associated | relid=0 | w=10
- mitoxantrone ---
r_associated #0: 10 -->
alloxane
n1=mitoxantrone | n2=alloxane | rel=r_associated | relid=0 | w=10
- mycotoxine ---
r_associated #0: 10 -->
alloxane
n1=mycotoxine | n2=alloxane | rel=r_associated | relid=0 | w=10
- méthotrexate ---
r_associated #0: 10 -->
alloxane
n1=méthotrexate | n2=alloxane | rel=r_associated | relid=0 | w=10
- orotate ---
r_associated #0: 10 -->
alloxane
n1=orotate | n2=alloxane | rel=r_associated | relid=0 | w=10
- procarbazine ---
r_associated #0: 10 -->
alloxane
n1=procarbazine | n2=alloxane | rel=r_associated | relid=0 | w=10
- vinblastine ---
r_associated #0: 10 -->
alloxane
n1=vinblastine | n2=alloxane | rel=r_associated | relid=0 | w=10
- éflornithine ---
r_associated #0: 10 -->
alloxane
n1=éflornithine | n2=alloxane | rel=r_associated | relid=0 | w=10
- étoposide ---
r_associated #0: 10 -->
alloxane
n1=étoposide | n2=alloxane | rel=r_associated | relid=0 | w=10
- barbiturate ---
r_associated #0: 5 -->
alloxane
n1=barbiturate | n2=alloxane | rel=r_associated | relid=0 | w=5
- cladribine ---
r_associated #0: 5 -->
alloxane
n1=cladribine | n2=alloxane | rel=r_associated | relid=0 | w=5
- cytosine ---
r_associated #0: 5 -->
alloxane
n1=cytosine | n2=alloxane | rel=r_associated | relid=0 | w=5
- dipyridamole ---
r_associated #0: 5 -->
alloxane
n1=dipyridamole | n2=alloxane | rel=r_associated | relid=0 | w=5
- diabète induit dû à l'alloxane ---
r_associated #0: 2 -->
alloxane
n1=diabète induit dû à l'alloxane | n2=alloxane | rel=r_associated | relid=0 | w=2
- diabète induit par l'alloxane ---
r_associated #0: 2 -->
alloxane
n1=diabète induit par l'alloxane | n2=alloxane | rel=r_associated | relid=0 | w=2
|